Skip to main content
OpenTrials
Completed

NCT Number: NCT02397850

Development of a Telephone-based Continuation Treatment for Patients With Chronic Depression.

There is a high risk for relapse in people suffering from depression. Studies indicate that the continuation of an acute psychotherapeutic treatment can reduce the likelihood of relapse. Therefore, this pilot study is aimed to investigate the feasibility of a continuation psychotherapy over 6 months, to support people suffering from chronic forms of depression in their daily life. The investigated continuation therapy itself includes about one telephone call per month (therapist - patient), focussing on the integration of strategies into the patient's daily routine. The patients receive either 30 minutes or 50 minutes phone calls. On the one hand, these phone calls are supported by a workbook for patients containing psychoeducative elements, strategies and exercises. On the other hand, the therapist's work is based on a manual containing several modules and strategies. Both tools (workbook, manual) are understood as a framework, using the appropriate sections according to the patient's needs. As a result, the patients receive a continuation treatment which is appropriate and adapted to their individual situation.

The main purpose of this pilot study is to evaluate the feasibility of a telephone based psychotherapeutic continuation treatment with a small sample of 20 patients suffering from chronic depression. In case of promising results the effectiveness of this kind of treatment is going to be investigated within a comparative trial (including face-to-face intervention, no intervention).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UniversitätsSpital Zürich Klinik für Psychiatrie und Psychotherapie Ambulatorium

Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent
  • Diagnosis of chronic (300.4) or recurrent (296.31-3) depression (according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition)
  • Currently in partial or full remission
  • Previous psychotherapy (acute treatment; some kind of cognitive-behavioral therapy)
  • adequate knowledge of German language
  • in case of taking antidepressants: long-term and stable dosage (with unchanged taking since 3 months at least)

Exclusion criteria

  • acute suicidality
  • psychotic symptoms
  • severe cognitive impairments
  • in case of taking antidepressants: anticipated stopping medication within treatment period (6 months)

Treatment and study plan

phone calls 30 min

Behavioral

Patients receive either seven 30 minutes phone calls over 6 months (psychotherapy/continuation treatment)

phone calls 50 min

Behavioral

Patients receive either seven 50 minutes phone calls over 6 months (psychotherapy/continuation treatment)

Primary outcomes

  1. number of patients dropping out of treatment

    Time frame: 6 months

  2. change of depressive symptoms from baseline to posttreatment

    Time frame: 6 months

    assessed by the Patient Health Questionnaire

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Optimizing Psychotherapeutic Aftercare for Patients Suffering From Chronic/Recurrent Depression: Development and First Evaluation of a Telephone-based Continuation Treatment (Pilot Study).

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Mar 25, 2015
Registry last updated
Nov 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.